IRCT20090117001556N137尚未招募2 期
Fingolimod as an adjuvant therapy added to Risperidone in the treatment of schizophrenia : A randomized double blind and placebo controlled clinical trial
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- All
入选标准
- •Diagnosis of schizophrenia based on DSM-5
- •Minimum score of 60 based on PANSS
- •Age range: 18-60 years old
- •At least, 2 years have passed since the onset of the disorder
排除标准
- •Diagnosis of another disorder in axis II
- •Existence of a significant neurological or organic disease
- •IQ less than 70 based on interviewer clinical suspicion
- •Substance/drug dependence during the last 6 months (except nicotine and caffeine)
- •Use of antipsychotics during past 1 week or long-term antipsychotics during past 1 month
- •Receiving ECT during the last 2 weeks
- •Abnormal endocrine activity
- •Abnormal kidney and liver function
- •History of thrombosis and emboli
- •History of abnormal bleeding
研究者
相似试验
已完成
2 期
Riluzole in the treatment of autismChildhood autism.Childhood autismIRCT201107281556N27Tehran University of Medical Sciences40
招募中
3 期
Folinic acid in the treatment of autism spectrum disorderAutistic disorder.Autistic disorderF84.0IRCT20090117001556N114Tehran University of Medical Sciences50
进行中（未招募）
1 期
Imiquimod therapy after surgical removal of anal HPV-lesions to reduce likelihood of recurrenceEUCTR2017-000842-23-ATMedical University Innsbruck200
已完成
2 期
Riluzole in the treatment of major depressioMajor Depressive episode.Major Depressive episodeIRCT201307181556N54Tehran University of Medical Sciences40
尚未招募
2 期
The efficacy of Ropinirole in the improvement of ADHDADHD.Attention-deficit hyperactivity disorder, combined typeF90.2IRCT20090117001556N151Tehran University of Medical Sciences50